Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label Generic sofosbuvir-based. Show all posts
Showing posts with label Generic sofosbuvir-based. Show all posts
Wednesday, September 12, 2018

Hepatitis C - Generic sofosbuvir-based interferon-free direct acting antiviral agents: a real-world multicenter observational study

›
In The News Monday, September 24, 2018 Gilead Subsidiary to Launch Authorized Generics of Epclusa® (Sofosbuvir/Velpatasvir) and Harvoni...
Thursday, July 27, 2017

Hepatitis drugs more affordable but disease still deadly: WHO

›
Hepatitis drugs more affordable but disease still deadly: WHO Stephanie Nebehay GENEVA ( Reuters ) - Prices of drugs to cure hepatitis ...
Wednesday, July 26, 2017

Hepatitis C - Mylan Receives WHO Prequalification for Generic Sovaldi®

›
Mylan Receives WHO Prequalification for Generic Sovaldi® First Generic Prequalification for Sofosbuvir Tablets HERTFORDSHIRE, England a...
Friday, July 21, 2017

WHO prequalifies first generic hepatitis C medicine and first HIV self-test

›
In the lead-up to Paris AIDS conference, WHO prequalifies first generic hepatitis C medicine and first HIV self-test Hepatitis C WHO tod...
Thursday, July 20, 2017

Towards supporting greater and lower cost access to direct acting antiviral treatment for hepatitis C for all patients

›
Saudi J Gastroenterol [serial online] 2017 [cited 2017 Jul 20];23:263-4. Available from:  http://www.saudijgastro.com/text.asp?2017/23/4/263...
Tuesday, May 23, 2017

Treatment with generic ledipasvir-sofosbuvir for 8 to 12 weeks was affective in Chinese patients with HCV genotype 1b

›
In the Journals Generic ledipasvir-sofosbuvir achieved SVR12 in HCV genotype 1b May 23, 2017 Healio Treatment with generic ledipasvir-so...
Wednesday, May 17, 2017

Costs for generic hepatitis C drugs available in India would be paid back in 5 to 10 years

›
PLOS ONE Published: May 17, 2017 https://doi.org/10.1371/journal.pone.0176503 Full Text Article Cost-effectiveness of hepatitis C treatme...
Tuesday, April 4, 2017

Sofosbuvir - WHO prequalifies first generic active ingredient for hepatitis C medicines

›
WHO prequalifies first generic active ingredient for hepatitis C medicines On 31 March 2017, WHO for the first time prequalified a generi...
Thursday, February 9, 2017

Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: a real-life observational study

›
Journal of Hepatology Lay summary The expensiveness of Harvoni® led to restrictions and access limitations in many developing and even ...
Thursday, December 22, 2016

Generic Sofosbuvir Underperforms in Real World, May Be Due to Suboptimal Regimens

›
AASLD 2016: Generic Sofosbuvir Underperforms in Real World, May Be Due to Suboptimal Regimens HCV Treatment Published on Thursday, 15 D...